Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.

Autor:	Meloni, Alison R.1, DeYoung, Mary Beth1 MaryBeth.DeYoung@bms.com, Han, Jenny1, Best, Jennie H.1, Grimm, Michael1
Zdroj:	Cardiovascular Diabetology. 2013, Vol. 12 Issue 1, p1-14. 14p. 4 Charts, 4 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu